T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Entergy
ETR
$46.7B
| $89.2M | 0.01% |
776,961
+22,135
| +3% | +$2.5M |
|
727
Tyra Biosciences
TYRA
$1.48B
| $88.9M | 0.01% |
2,782,567
+1,796,506
| +182% | +$59.4M |
|
728
Travel + Leisure Co
TNL
$3.91B
| $88.3M | 0.01% |
1,154,826
+582,172
| +102% | +$40.9M |
|
729
Ferguson
FERG
$43.9B
| $87.6M | 0.01% |
369,165
+39,029
| +12% | +$9.42M |
|
|
P
730
Everpure Inc
P
$43.3B
| $87.6M | 0.01% |
1,111,828
+175,796
| +19% | +$12.9M |
|
731
Dyne Therapeutics
DYN
$3.02B
| $87.4M | 0.01% |
3,936,806
+1,608,433
| +69% | +$29.9M |
|
732
Pricesmart
PSMT
$5.34B
| $87.2M | 0.01% |
446,182
+222,840
| +100% | +$37.2M |
|
733
Stoke Therapeutics
STOK
$1.62B
| $87.1M | 0.01% |
2,661,739
+727,568
| +38% | +$23.3M |
|
734
Boot Barn
BOOT
$3.78B
| $85.6M | 0.01% |
520,826
-76,292
| -13% | -$12.4M |
|
735
Abercrombie & Fitch
ANF
$5.75B
| $83.8M | 0.01% |
930,739
+368,149
| +65% | +$31.2M |
|
736
Aflac
AFL
$57B
| $83.7M | 0.01% |
714,049
-68,136
| -9% | -$7.84M |
|
737
Paylocity
PCTY
$7.66B
| $83.4M | 0.01% |
798,039
+155,853
| +24% | +$16.6M |
|
738
Tenaris
TS
$28.5B
| $83.4M | 0.01% |
1,502,839
+57,629
| +4% | +$3.5M |
|
739
IonQ
IONQ
$18.7B
| $83.4M | 0.01% |
1,565,044
+128,385
| +9% | +$6.51M |
|
740
UMB Financial
UMBF
$10.2B
| $83.3M | 0.01% |
583,289
-24,025
| -4% | -$3.09M |
|
741
Realty Income
O
$52.3B
| $82.9M | 0.01% |
1,338,537
+34,649
| +3% | +$2.16M |
|
742
Teck Resources
TECK
$31.7B
| $82.4M | 0.01% |
1,384,990
+4,988
| +0.4% | +$304K |
|
743
IDEAYA Biosciences
IDYA
$3.73B
| $82.3M | 0.01% |
2,207,451
+891,582
| +68% | +$27.3M |
|
744
Zoetis
ZTS
$29.4B
| $81.9M | 0.01% |
1,139,097
+121,009
| +12% | +$11.4M |
|
745
Advanced Energy
AEIS
$11.1B
| $81.8M | 0.01% |
219,468
-34,926
| -14% | -$12.2M |
|
746
Denali Therapeutics
DNLI
$3.36B
| $80.7M | 0.01% |
3,136,149
+672,003
| +27% | +$13.8M |
|
747
Iron Mountain
IRM
$33.1B
| $80.2M | 0.01% |
634,613
+33,032
| +5% | +$4.05M |
|
|
TTAN
748
ServiceTitan Inc
TTAN
$5.7B
| $79.8M | 0.01% |
1,128,804
+44,816
| +4% | +$2.89M |
|
|
ORKA
749
Oruka Therapeutics
ORKA
$5.65B
| $79.8M | 0.01% |
838,603
+111,154
| +15% | +$7.41M |
|
750
Oneok
OKE
$56B
| $79.4M | 0.01% |
912,865
-1,638,835
| -64% | -$144M |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.